Efficacy and Safety of AP 12009 in Adult Patients with Recurrent or Refractory Anaplastic Astrocytoma (WHO grade III) as compared to Standard treatment with Temozolomide or BCNU : A Randomised Actively Controlled Open Label Clinical Phase III study. {SAPPHIRE Study} Research Project uri icon